Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction

Saved in:
Bibliographic Details
Published inSignal transduction and targeted therapy Vol. 6; no. 1; p. 198
Main Authors Lin, ChangDong, Li, Yue, Zhang, YueBin, Liu, ZhaoYuan, Mu, Xia, Gu, Chenjian, Liu, Jing, Li, Yutang, Li, GuoHui, Chen, JianFeng
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 18.05.2021
Nature Publishing Group
Subjects
631/154/1435
631/250/254
631/45/535
ACE2
Angiotensin-converting enzyme 2
Cancer Research
Ceftazidime
Cell Biology
Internal Medicine
Letter
Medicine
Medicine & Public Health
Oncology
Pathology
Severe acute respiratory syndrome coronavirus 2
Spike protein
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:2059-3635
2095-9907
2059-3635
DOI:10.1038/s41392-021-00619-y